相关实验视频
Updated: Sep 15, 2025

09:49
Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
1.4K
基于机器学习的肺炎相关急性呼吸困扰综合征预测模型
Jing Lv1, Juan Chen1, Meijun Liu1
1Department of Pulmonary and Critical Care Medicine, The First Batch of Key Disciplines on Public Health in Chongqing, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Frontiers in medicine
|July 18, 2025
概括
这项研究开发了一种机器学习模型,用于预测肺急性呼吸窘迫综合征 (p-ARDS) 患者的28天死亡率. 该模型利用了共同的临床特征,显示了良好的预测性能,并提供了一个有价值的风险评估工具.
科学领域:
- 医疗信息学 医疗信息学
- 关键护理医学 关键护理医学
- 机器学习应用 机器学习应用
背景情况:
- 肺急性呼吸窘迫综合征 (p-ARDS) 在重症监护中提出了重大挑战.
- 准确的预后分析对于及时干预和改善患者结果至关重要.
- 现有的预测模型可能缺乏先进的机器学习技术的预测能力.
研究的目的:
- 构建和验证机器学习预测模型,用于p-ARDS患者的预后分析.
- 在p-ARDS中确定与28天死亡率相关的关键临床变量.
- 为了评估不同的机器学习算法对p-ARDS预后的性能.
主要方法:
- 一项回顾性研究包括230名p-ARDS患者,根据28天的结果分为生存和死亡组.
- 六个机器学习模型 (逻辑回归,随机森林,天真贝叶斯,SVM,XGBoost,Adaboost) 被训练并使用临床数据在入院后24小时内进行测试.
- 模型性能使用AUC,AP,精度,灵敏度,特异性,布里尔得分和F1得分进行评估,并使用SHAP进行特征重要性分析.
主要成果:
- 十个关键变量,包括年龄,LAR,Lac,pH,PO2/FiO2,ALB,BMI,TP,PT和DBIL,被确定为重要的预测因素.
- 发现年龄是死亡率最重要的预测因素.
- 支持矢量机 (SVM) 算法表现出卓越的性能,在测试组中实现了0.77的AUC,0.74的准确性和0.81的特异性.
结论:
- 基于10个常见的临床特征的机器学习模型可以有效预测p-ARDS患者的28天死亡率.
- 开发的模型,增强了SHAP的解释性,为死亡风险评估提供了一个可靠的工具.
- 这种方法突显了机器学习在重症监护预后和个性化患者管理方面的潜力.
相关概念视频
Pneumonia III: Complications and Assessment
447
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
447
Pneumonia I: Introduction
333
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
333
Pneumonia IV: Management
453
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
453
Pneumonia V: Nursing management and Prevention
2.5K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.5K
Acute Respiratory Failure-V
211
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
211
Acute Respiratory Failure-II
371
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
371

